Picture of Bioservo Technologies AB logo

BIOS — Bioservo Technologies AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bioservo Q3 EBITDA SEK -9.3 Million

Nov 07 (Reuters) - Bioservo Q3 adjusted free cash flow SEK 15.2 million.
* Q3 sales SEK 4.2 million
* Q3 EBIT SEK -9.8 million
* Q3 adjusted EPS SEK -0.12

Recent news on Bioservo Technologies AB

See all news